Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J0570 Buprenorphine implant 74.2mg

J Codes (Drugs)

Also known as: buprenorphine implant, Probuphine

Buprenorphine implant containing 74.2 milligrams for subdermal insertion, providing sustained opioid substitution therapy for opioid use disorder.

In Plain Language

subdermal opioid replacement chip; long-term addiction treatment

Clinical Context

Used for maintenance treatment of opioid use disorder in patients stable on buprenorphine. Single subdermal implant placed in upper arm provides therapeutic levels for 6 months, improving medication adherence.

RVU Information

CPT J0570 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

addiction medicinepain managementpsychiatry

Frequently Asked Questions

What is CPT code J0570?

CPT J0570 (Buprenorphine implant 74.2mg) is a J Codes (Drugs) code. Buprenorphine implant containing 74.2 milligrams for subdermal insertion, providing sustained opioid substitution therapy for opioid use disorder.

How is J0570 administered?

CPT J0570 is administered by a healthcare provider, typically via injection or infusion. Used for maintenance treatment of opioid use disorder in patients stable on buprenorphine. Single subdermal implant placed in upper arm provides therapeutic levels for 6 months, improving medication adherence. It is used by addiction medicine, pain management, psychiatry.

When is CPT J0570 used?

Used for maintenance treatment of opioid use disorder in patients stable on buprenorphine. Single subdermal implant placed in upper arm provides therapeutic levels for 6 months, improving medication adherence.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.